Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for allegedly making materially false statements and failing to disclose adverse information regarding its business and financial practices during the specified Class Period [1][3]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for investors who purchased Ardent Health securities between July 18, 2024, and November 12, 2025 [1]. - Investors have until March 9, 2026, to seek appointment as lead plaintiff in the class action [2]. Group 2: Allegations Against Ardent Health - The complaint alleges that Ardent Health and its executives misrepresented the company's reliance on historical collection reviews, which were claimed to be a primary source of information for determining collectability [4]. - In reality, the company allegedly used a 180-day threshold for accounts to become fully reserved, leading to inflated accounts receivable balances and delayed recognition of losses [5]. Group 3: Financial Impact - On November 12, 2025, Ardent Health disclosed a $43 million reduction in quarterly revenue and a $54 million increase in professional liability reserves, which were attributed to adverse prior-period claim developments [6]. - Following these disclosures, Ardent Health's stock price fell approximately 33%, from $14.05 to $9.30 per share, resulting in significant losses for investors [7].
ARDT Investors Encouraged to Seek Lead Plaintiff Role in Ardent Health, Inc. Securities Class Action with Johnson Fistel